Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
MCG selected as designated laboratory for NCI-MATCH trial

MCG selected as designated laboratory for NCI-MATCH trial

UCLA researchers investigate how a protein factor contributes to cancer cell migration

UCLA researchers investigate how a protein factor contributes to cancer cell migration

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Study shows how machinery within immune system activates T cells to attack cancer

Study shows how machinery within immune system activates T cells to attack cancer

Barcelona researchers win one of the most prestigious EU grants to study CLL

Barcelona researchers win one of the most prestigious EU grants to study CLL

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

Scientists identify new target for battling deadly form of leukemia

Scientists identify new target for battling deadly form of leukemia

MIT researchers devise way to help blood cells regenerate after radiation therapy

MIT researchers devise way to help blood cells regenerate after radiation therapy

Researchers find pesticide residues lurking in rural NYS homes

Researchers find pesticide residues lurking in rural NYS homes

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

Study suggests new approach to treat life-threatening blood disorder in children

Study suggests new approach to treat life-threatening blood disorder in children

Eight promising biomedical research projects receive ASH Bridge Grants

Eight promising biomedical research projects receive ASH Bridge Grants

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

'Supercharged' immune cells could help fight cancer

'Supercharged' immune cells could help fight cancer

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.